FOR IMMEDIATE RELEASE
Miami, Florida — March 26, 2026
Miami’s eMed Secures $200 Million Series A at $2 Billion+ Valuation, Appoints Tom Brady as Founding Chief Wellness Officer
Aon Consulting Leads Landmark Round as eMed Moves to Transform Employer Healthcare Through Agentic AI and GLP-1 Access
MIAMI, FL — Miami-based digital health company eMed announced on March 26, 2026 that it has closed a $200 million Series A funding round, valuing the company at more than $2 billion — cementing its status as one of South Florida’s most prominent healthcare technology unicorns.
The round was led by Aon Consulting, Inc., with participation from a high-profile group of investors including NFL legend and eMed Founding Chief Wellness Officer Tom Brady, former X CEO and media executive Linda Yaccarino, and eMed founder and chairman Jeff Aronin.
About eMed
Founded and headquartered in Miami, Florida, eMed is an employer-focused telehealth and digital health platform that leverages agentic artificial intelligence to deliver personalized, accessible healthcare solutions to employees across the United States. The company specializes in connecting employers with high-impact health interventions, including cutting-edge GLP-1 medication programs for weight management and metabolic health.
Under the leadership of CEO Dr. Patrice Harris, eMed has grown rapidly by addressing the rising cost burden that healthcare places on American employers, offering a scalable AI-driven platform that reduces costs while improving employee health outcomes.
Use of Funds
eMed plans to deploy the $200 million raise to accelerate its agentic AI platform development, expand access to GLP-1 medications for employer-covered populations, and drive national growth. The funding will also support the development of new employer health models designed to reduce healthcare spending while delivering better outcomes for working Americans.
High-Profile Investor Backing
The involvement of Tom Brady, widely recognized as one of the greatest NFL players of all time, in his role as Founding Chief Wellness Officer signals eMed’s commitment to elevating health and performance culture in the workplace. Brady brings his personal commitment to optimal health and longevity to the company’s mission of making quality healthcare accessible to all employees.
Linda Yaccarino, the former CEO of X (formerly Twitter) and a prominent figure in media and technology, joins the round as a strategic investor, reflecting eMed’s growing reputation at the intersection of technology and healthcare innovation.
South Florida’s Health Tech Scene
eMed’s milestone is a major win for Miami’s burgeoning technology and life sciences ecosystem. The company’s $2 billion+ valuation ranks it among the most valuable health tech companies to emerge from Florida, reinforcing Miami’s growing reputation as a hub for venture-backed innovation.
South Florida’s fintech, health tech, and enterprise software sectors have seen significant investment inflows in recent years as companies relocate from higher-cost markets, and eMed’s Series A round represents one of the largest health tech funding events in the region’s history.
About the Investors
Aon Consulting, Inc. is a global professional services firm specializing in risk, health, and retirement
solutions. As the lead investor in this round, Aon’s participation underscores the strategic alignment between its employer health advisory business and eMed’s platform capabilities.
Contact Information
Florida’s Growing Health Tech and Wellness Ecosystem: Related Stories
eMed’s landmark $200 million Series A round is more than a single company milestone — it reflects a broader surge of innovation, investment, and health-focused entrepreneurship reshaping Florida’s business landscape. From cutting-edge biotech deals in Tampa to pioneering longevity science in South Florida and AI-driven solutions transforming how businesses operate, the Sunshine State is rapidly emerging as a national leader in health, wellness, and technology. Explore these related stories that underscore the momentum building across the region.
Florida’s biotech sector is gaining national attention alongside eMed’s health tech breakthrough. The Tampa biotech firm BioNova Health Sciences landed a $50 million strategic partnership deal with global pharmaceutical leader MedAxis International, pledging over 300 high-wage jobs across the Tampa Bay region. Like eMed’s mission to transform employer healthcare, BioNova’s focus on advanced diagnostics and personalized medicine signals that Florida is becoming a serious hub for life sciences investment and innovation.
The wellness revolution driving eMed’s growth extends well beyond digital health platforms. South Florida is home to pioneering research in longevity and cellular health, with companies like Senolytix leading the way in South Florida anti-aging treatments and senolytic therapy — targeting the root causes of age-related decline at the cellular level. As eMed leverages AI and GLP-1 medications to improve metabolic health, Senolytix’s breakthroughs in eliminating senescent cells represent the cutting edge of the same longevity-focused healthcare movement taking root across the region.
Proactive, preventative healthcare is also gaining momentum across South Florida’s professional communities. Dr. Brett Osborn’s practice in Palm Beach County stands as a model for the future of medicine, offering a holistic, data-driven approach that mirrors eMed’s philosophy of optimizing employee health before problems escalate. Learn more about how preventative medicine in Palm Beach County, Florida is redefining what it means to deliver personalized, outcome-focused care — the same values powering eMed’s rapid national expansion.
Central to eMed’s competitive advantage is its agentic AI platform, which automates and personalizes healthcare delivery at scale. This kind of AI innovation is no longer reserved for Silicon Valley — Florida-based firms are already deploying artificial intelligence across industries including healthcare, finance, and retail. Discover how Florida AI consultants at Florida AI Agency are helping businesses of all sizes harness machine learning, AI-driven automation, and intelligent analytics — the same technological foundation that makes eMed’s employer health platform one of the most disruptive in the country.
For more information about eMed and its employer healthcare solutions, visit www.emedhealth.com.
###
Source: PR Newswire / Reuters — March 26, 2026
